Matthew J Feinstein

  • 633 Citations
20042023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Matthew Feinstein, MD MSc is a cardiologist at Northwestern Medicine and an assistant professor at the Northwestern University Feinberg School of Medicine with a dual appointment in the Department of Medicine and Department of Preventive Medicine Dr. Feinstein is a physician-scientist with expertise in immune and inflammatory triggers of cardiovascular diseases. Much of Dr. Feinstein's work has analyzed human immunodeficiency virus (HIV) as a model of chronic immune dysregulation leading to cardiovascular disease. Dr. Feinstein is an elected Fellow of the American Heart Association (AHA), served as writing chair of the AHA Scientific Statement on HIV and cardiovascular disease (https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000000695?af=R), and is actively involved as an elected investigator and faculty contributor on several AHA committees. He also serves as an investigator for the AIDS Clinical Trials Group End-Organ Disease and Inflammation Transformative Science Group as well as the Pediatric HIV/AIDS Cohort Study Metabolic Working Group. Dr. Feinstein was awarded an American Society of Clincial Investigation (ASCI) Young Investigator Award, and was voted a finalist for the AHA Stamler Award for New Investigators and the ACC Young Investigator Award Competition. He was a recipient of the prestigious AHA Fellow-to-Faculty Transition Award and has also received grant funding for his work from the National Institutes of Health. He and his work have been featured nationally on ABC World News Tonight, CBS, Time Magazine, Fox News, the Chicago Tribune, and NPR, as well as internationally on Voice of America, the Economic Times, African Medical Digest, and the Gulf Times. Dr. Feinstein received his bachelor of arts in sociology from Princeton University. He received his MD and MS in clinical investigation from Northwestern University Feinberg School of Medicine. He completed his internship and residency in internal medicine at Northwestern University and completed his fellowship in cardiovascular medicine at Northwestern University.

Certifications and Licenses

Internal Medicine
Cardiology

Education/Academic qualification

MD, Northwestern University Feinberg School of Medicine

… → 2011

Fingerprint Dive into the research topics where Matthew J Feinstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
HIV Medicine & Life Sciences
Cardiovascular Diseases Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Atherosclerosis Medicine & Life Sciences
Heart Failure Medicine & Life Sciences
Carotid Artery Diseases Medicine & Life Sciences
Cardiac Arrhythmias Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2023

Research Output 2004 2019

4 Citations (Scopus)

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living with HIV: A Scientific Statement from the American Heart Association

American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention and Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Stroke Council, Jul 9 2019, In : Circulation. 140, 2, p. e98-e124

Research output: Contribution to journalArticle

Open Access
Cardiovascular Diseases
HIV
Chronic Disease
Randomized Controlled Trials
Heart Failure
1 Citation (Scopus)

Coronary Artery Disease Manifestations in HIV: What, How, and Why

Sinha, A. & Feinstein, M. J., Mar 1 2019, In : Canadian Journal of Cardiology. 35, 3, p. 270-279 10 p.

Research output: Contribution to journalReview article

Coronary Artery Disease
HIV
Inflammation
Toll-Like Receptor 2
Tobacco Use
2 Citations (Scopus)

Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction

Delaney, J. A., Nance, R. M., Whitney, B. M., Crane, H. M., Williams-Nguyen, J., Feinstein, M. J., Kaplan, R. C., Hanna, D. B., Budoff, M. J., Drozd, D. R., Burkholder, G., Mugavero, M. J., Mathews, W. C., Moore, R. D., Eron, J. J., Hunt, P. W., Geng, E., Saag, M. S., Kitahata, M. M. & Heckbert, S. R., Jan 1 2019, In : Epidemiology. 30, 1, p. 69-74 6 p.

Research output: Contribution to journalArticle

Viremia
Myocardial Infarction
Viral Load
Confidence Intervals
Therapeutics

Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons

Riestenberg, R. A., Furman, A., Cowen, A., Pawlowksi, A., Schneider, D., Lewis, A. A., Kelly, S., Taiwo, B. O., Achenbach, C. J., Palella Jr, F. J., Stone, N. J., Lloyd-Jones, D. M. & Feinstein, M. J., Mar 1 2019, In : American heart journal. 209, p. 79-87 9 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
HIV
Lipids
HIV Infections
Cardiovascular Diseases
3 Citations (Scopus)
Heart Failure
Mortality